CREATING A DRUG DISPENSING OPHTHALMIC DEVICE WITH INTEGRATED MODULAR ELEMENTS

1 . A method comprising:

creating an integrated device comprising:

mating an interconnect interface of an electronic control module (ECM) to a passive interconnect interface of a primary drug container module (PDCM);

forming an electrical connection between the interconnect interface of the ECM to the passive interconnect interface of the PDCM, wherein the ECM is active and the PDCM is passive; and

encapsulating the integrated device within a body of an ophthalmic device.

2 . The method of claim 1 , further comprising manufacturing and storing the ECM and the PDCM in different environments.

3 . The method of claim 1 , further comprising manufacturing the ECM, comprising:

fabricating a flexible substrate;

bonding at least one component electrical chip and at least one interconnect interface to the flexible substrate to form the ECM;

sterilizing the ECM using an electronic-safe technique; and

storing the ECM in an electronic safe packaging and environment.

4 . The method of claim 1 , further comprising manufacturing the PDCM, comprising:

fabricating at least one reservoir in a substrate, wherein each of the at least one reservoir comprises a storage volume;

sterilizing the at least one reservoir using at least one of gamma radiation, ETO, autoclave or e-beam;

filling the storage volume of each of the at least one reservoir with at least one drug;

covering an opening of each of the at least one reservoir with an electrode to secure the at least one drug in each of the at least one reservoir;

sealing the PDCM to keep the at least one drug under hermetic or near hermetic storage conditions;

attaching the passive interconnect interface; and

storing the PDCM in sterile packaging and according to storage instructions for the at least one drug.

5 . The method of claim 1 , further comprising:

mating another interconnect interface of the ECM with a passive interconnect interface of another PDCM; and

forming an electrical connection between the other interconnect interface of the ECM to the passive interconnect interface of the other PDCM.

6 . The method of claim 5 , further comprising storing the other PDCM separately from the PDCM based on different storage instructions for at least one drug in the PDCM and at least one other drug in the other PDCM.

7 . An ophthalmic device comprising:

an electronic control module (ECM) comprising an interconnect interface;

a primary drug container module (PDCM) comprising a passive interconnect interface, wherein the passive interconnect interface of the PDCM is mated with the interconnect interface of the ECM, wherein the PDCM is passive and the ECM is active; and

a body comprising a biocompatible material safe for ocular wear.

8 . The ophthalmic device of claim 7 , wherein the ECM comprises active electronics of the ophthalmic device.

9 . The ophthalmic device of claim 7 , wherein the PDCM comprises no active electronics, components, chips, and/or semiconductor-based materials.

10 . The ophthalmic device of claim 7 , wherein the PDCM comprises at least one reservoir configured to store at least one drug and an electrode covering an opening of each of the at least one reservoir, wherein the electrode is configured to electrodissolve to release the at least one drug when a signal is delivered from the ECM.

11 . The ophthalmic device of claim 7 , wherein the PDCM further comprises a plurality of reservoirs configured to store one or more drugs.

12 . The ophthalmic device of claim 11 , wherein the one or more drugs are the same at least one drug per reservoir or different at least one drug per reservoir.

13 . The ophthalmic device of claim 11 , wherein each of the plurality of reservoirs is uniquely addressable via an electronic lead formed by the mating of the passive interconnect interface of the PDCM and the interconnect interface of the ECM.

14 . The ophthalmic device of claim 7 , wherein the ECM comprises electronic components disposed on a polymer substrate, where the electronic components comprise an application specific integrated circuit (ASIC), an oscillator, a battery, a capacitor, and/or an antenna.

15 . The ophthalmic device of claim 7 , wherein the ECM comprises a plurality of interconnect interfaces, further comprising:

at least one other PDCM comprising another passive interconnect interface,

wherein the other passive interconnect interface of the at least one other PDCM is mated with another of the plurality of interconnect interfaces of the ECM.

16 . The ophthalmic device of claim 15 , wherein each of the PDCM and the other PDCM comprise one or more reservoirs providing a stand-alone, sealed, and sterile storage environment for one or more drugs.

17 . A method comprising:

choosing a first primary drug container module (PDCM) for a patient based on a disorder of an eye of the patient and at least one drug stored in the first PDCM;

choosing at least a second PDCM for the patient based on the disorder of the eye of the patient and at least one other drug stored in the second PDCM;

mating the first PDCM to a first interconnect interface of an electronic control module (ECM) to form an integrated device,

mating the at least the second PDCM to at least a second interconnect interface of the ECM to add to the integrated device; and

encapsulating the integrated device within in a body of an ophthalmic device.

18 . The method of claim 17 , wherein the choosing the first PDCM and the at least the second PDCM further comprises choosing at least two drugs that interact for improved efficacy of treatment of the disorder of the eye.

19 . The method of claim 17 , further comprising treating the disorder of the eye with the ophthalmic device, wherein the at least one drug is actively dispensed to the eye using the ECM and the first PDCM and the at least one other drug is dispensed to the eye using the ECM and the at least the second PDCM.

20 . The method of claim 19 , wherein treating the disorder of the eye with the ophthalmic device further comprises choosing a schedule of delivery of the at least one drug and the at least one other drug.